Preventing group B streptococcal infections: New recommendations

Group B streptococcal infections.

1. Know the mode of transmission of group B Streptococcus (GBS) and the peripartum risk factors associated with a high risk of infection. 2. Know the major clinical manifestations of GBS and be able to differentiate the epidemiology and clinical presentation of early onset GBS disease from that of lateonset disease. 3. Know the laboratory testing for GBS: isolation, antigen detection, and susce...

Group B Streptococcal Infections.

Group B streptococcal disease remains a prominent cause of infectious morbidity in pregnant women and their infants. This article highlights recent developments that are relevant for obstetricians, perinatologists, and neonatologists caring for patients with group B streptococcal disease. The morbidity of group B streptococcal infections in pregnancy and the proposed association of colonization...

Group B streptococcal infections.

Pathogenesis of neonatal group B streptococcal infections.

Infections of the neonate due to the group B Streptococcus have been recognized since the 1930s, but it was during the 1970s that their incidence grew alarmingly throughout the world. A research effort stimulated by this problem has yielded significant new information about many facets of the pathogenesis of these infections. Immunologic investigations have pinpointed a lack of transplacentally...

Group B streptococcal infections in newborns.

Group B streptococcus (GBS) is the most common cause of neonatal infection in North America and is associated with morbidity and mortality. Prompt recognition and treatment of the infection is imperative. Diagnostic tests and treatment options vary, without clear research-based recommendations. Future trends should focus on GBS infection as a public health issue, with an emphasis on prevention.